1/26
Looks like no tags are added yet.
Classes of Lipoproteins
- Chylomicrons
- Very-low density lipoproteins (VLDL)
- intermediate density lipoprotein (IDL)
- Low density lipoproteins (LDL)
- High density lipoprotein (HDL)
exogeneous vs. endogeneous lipid transport
exogeneous
- dietary lipids --> chylomicrons --> peripheral tissues --> chylomicron remnants --> liver
endogeneous
- liver --> VLDL --> IDL --> LDL --> peripheral tissues / liver
reverse cholesterol transport system
peripheral tissues --> HDL --> liver --> cholesterol conversion or excretion through bile (salts or acid)
Lipoprotein density
- higher proportion of lipid = lower density
- largest + least dense = chylomicrons (high lipid:protein)
-smallest + most dense = HDL
adipocytes: function
- major storage site for triacylglycerols
- common target of chylomicrons following fat-containing meal
adipocytes : what factors increase _ storage
- triacylglycerols
- amt of fat in a meal exceeds immediate energy demands of tissues
-increased insulin in the fed state stimulates lipoprotein lipase activity, increasing uptake of FFAs and monoacylglycerols
- glucose and insulin in bloodstream
- CHO rich meal
VLDL: role and what it carries
- endogeneous TGs and some cholesterol
- carries liver-produced lipids to peripheral tissues
lipoprotein structure
- hydrophobic core with triacylglycerols and cholesterol esters
- core surrounded by monolayer of amphipathic phospholipids + free chol
- surface apolipoproteins provide structural stability, activate enzymes, and act as ligands for cell receptors
chylomicrons: role, what it carries
- mostly dietary TGs
- transport dietary lipids from intestine to muscle and adipose tissue
-remnants taken up by liver
IDL: role, what it carries
intermediate particle formed as VLDL delivers TGs
- becomes LDL
LDL: role, what it carries
- cholesterol-rich
- primary carrier of cholesterol in the blood
- delivers cholesterol to tissues via LDL receptors
HDL: role, what it carries
- picks up excess cholesterol from peripheral tissues
- returns it to the liver for processing or excretion
LDL receptors: deficiencies, injuries, factors that decrease quantity
- deficiency: causes serum LDL cholesterol to rise
- oxidized LDL cholesterol deposited in injured areas of arterial walls
to decrease LDL receptor numbers:
- saturated fat intake
-trans fat intake
- obesity
- genetic mutations
to increase LDL receptor numbers:
- soluble fiber
- phytosterol intake
lipoprotein transport: liver
- newly synthesized FA and TGs made from glucose, fructose, and amino acids
- chylomicron remnants, LDL, and HDL
- FFAs taken up from the blood
fat storage
energy and carbohydrate availability high: fat storage
energy needed, blood glucose low: mobilization and oxidation of fat
Catabolism of TGs: WHY
in energy need (low cal intake, exercise), stored TGs metabolized to provide energy
complete hydrolysis makes: 1 glycerol, 3 FAs
Catabolism of TGs: enzymes involved
1. monoglyceride lipase
2. adipose triglyceride lipase
3. hormone-sensitive lipase
Fatty acids as an energy source, fate of LCFA, and B oxidation
- fatty acids are a RICH energy source
- LCFAs require carnitine to cross the inner mitochondrial membrane
- B oxidation occurs PRIMARILY in the mitochondria
- produces: acetyl co-A, NADH, and FADH2
ketogenesis and ketosis
accelerated fatty acid oxygen --> excess acetyl coA --> liver converts into ketone bodies
- triggers: low energy, low CHO intake, uncontrolled type I diabetes
ketosis: mild increase in blood ketones, typically not harmful
ketoacidosis: dangerously high blood ketones
what do ketone bodies consist of?
acetoacetate, B-hydroxybutyrate, acetone
synthesis of fatty acids
- from acetyl-coA
-major sites: liver, lungs, adipose tissues, lactating mammary glands, brain, and kidneys
- initial synthesi and fatty acid synthase system: cytosol
- elongation: two C units to chain
- elongation and denaturation of EFA precursors in sER
- EFA: linoleic acid (n-6), and a-linolenic acid (n-3)
eicosanoids
-prostoglandins, thromboxanes, leukotrienes
- n-6 arachidonic acid derived: generally proinflammatory, proarrthymic, activate platelets, cause vasoconstriction
- n-3 EPA-derived: anti inflammatory, antiarrthymatic, inhibit platelets, cause vasodilation
n-6 and n-3 FA compete for desaturases and elongases
regulation of fatty acid metabolism: role of BG levels
- adequate CHO intake inc. FA synthesis
- CHO defecit inc fatty acid oxidation
HIGH BG: insulin increases glucose transport and lipogenesis inhibits lipolysis
LOW BG: lipogenesis decreases, lipolysis increases, FFAs enter bloodstream, fatty acid oxidation increases
whole body cholesterol balance
input: body synthesis
output: biliary excretion
- cholesterol NOT required in diet, all cells can synthesize
- humans lack oxidative enzymes to eliminate cholesterol via oxidation
cholesterol synthesis
from acetyl coA
occurs in cytoplasm and smooth ER
liver accounts for 20% of endogeneous cholesterol synthesis
HMG CoA reductase: controls rate of cholesterol synthesis
cholesterol excretion
- secreted into bile as free cholesterol or converted into bile salts
- can be reabsorbed and returned to liver
- returning bile salts dec new bile salt formation
- preventing bile salts from returning inc formation from cholesterol, decreasing serum cholesterol
role of liver in regulation of cholesterol metabolism
liver:
- synthesizes cholesterol
- receives it from blood via lipoprotein receptors
- packages cholesterol esters into VLDL
- converts cholesterol into bile acids
- releases FC into bile for excretion
intracellular cholesterol inc:
-HMG-CoA reductase activity dec
- LDL receptor prod dec
- cholesterol esterification inc
- bile acid synthesis inc
intracellular cholesterol dec
- HMG-coA inc
- LDL receptor prod inc
- stored cholesterol esters hydrolyzed to release FC
- bile acid synthesis dec